학술논문

Phase II trial of domatinostat (4SC-202) in combination with avelumab in patients with previously treated advanced mismatch repair proficient oesophagogastric and colorectal adenocarcinoma: EMERGE
Document Type
Article
Source
In ESMO Open April 2024 9(4)
Subject
Gastrointestinal Cancers
Language
ISSN
2059-7029